Metastasis and Immune Evasion from Extracellular cGAMP Hydrolysis
Open accessPublished version of a preprint
The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Cytosolic DNA is characteristic of chromosomally unstable metastatic cancer cells, resulting in constitutive activation of the cGAS–STING innate immune pathway. How tumors co-opt inflammatory signaling while evading immune surveillance remains unknown. Here, we show that the ectonucleotidase ENPP1 promotes metastasis by selectively degrading extracellular cGAMP, an immune-stimulatory metabolite whose breakdown products include the immune suppressor adenosine. ENPP1 loss suppresses metastasis, restores tumor immune infiltration, and potentiates response to immune checkpoint blockade in a manner dependent on tumor cGAS and host STING. Conversely, overexpression of wild-type ENPP1, but not an enzymatically weakened mutant, promotes migration and metastasis, in part through the generation of extracellular adenosine, and renders otherwise sensitive tumors completely resistant to immunotherapy. In human cancers, ENPP1 expression correlates with reduced immune cell infiltration, increased metastasis, and resistance to anti–PD-1/PD-L1 treatment. Thus, cGAMP hydrolysis by ENPP1 enables chromosomally unstable tumors to transmute cGAS activation into an immune-suppressive pathway. Significance: Chromosomal instability promotes metastasis by generating chronic tumor inflammation. ENPP1 facilitates metastasis and enables tumor cells to tolerate inflammation by hydrolyzing the immunotransmitter cGAMP, preventing its transfer from cancer cells to immune cells. This article is highlighted in the In This Issue feature, p. 995
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chromosomal instability induces chronic inflammatory signals by constantly activating the cGAS‐STING signaling mechanism, which downstream NF‐κB function and consecutively increases metastatic cancer cell progression [256] (Figure 1).”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [256]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“For pathway enrichment analysis, the DESeq2 R package (45) was used to identify differentially expressed genes between the ENPP1CGAS and ENPP1CGAS groups within the TCGA BRCA cohort.”
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625 · cited 3×
“The sorted preranked list was run in GSEA with the Hallmark gene set database that was downloaded from the Molecular Signatures Database (46).”
MethodInfluentialRobust enumeration of cell subsets from tissue expression profiles
Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., & Alizadeh, A. A. (2015) · Nature Methods · doi:10.1038/nmeth.3337 · Cited by 13,224 · cited 1×
“We segregated 1,079 breast tumors into four subsets based on their relative CGAS and ENPP1 expression levels and used the CIBERSORT method to infer the prevalence of immune cell subsets from tissue expression profiles (34).”
MethodThe Immune Landscape of Cancer
Thorsson, V., Gibbs, D. L., Brown, S. D., Wolf, D., Bortone, D. S., Ou Yang, T.-H., Porta-Pardo, E., Gao, G. F., Plaisier, C. L., Eddy, J. A., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.023 · Cited by 5,870
Self-citationTGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
Mariathasan, S., Turley, S. J., Nickles, D., Castiglioni, A., Yuen, K., Wang, Y., Kadel III, E. E., Koeppen, H., Astarita, J. L., Cubas, R., et al. (2018) · Nature · doi:10.1038/nature25501 · Cited by 5,400 · cited 1×
“We next analyzed the mRNA expression levels of CGAS and ENPP1 in 228 bladder cancers treated with anti-PD-L1 (aPD-L1) therapy and a smaller cohort of 52 TNBC tumors treated with aPD1 (36,37).”
MethodCyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996 · cited 1×
“Cytosolic dsDNA is sensed by cGAS, which upon binding to its substrate, catalyzes the formation of the cyclic dinucleotide, cGAMP (13).”
BackgroundSTING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
Ishikawa, H., & Barber, G. N. (2008) · Nature · doi:10.1038/nature07317 · Cited by 3,576 · cited 1×
“A potent immune-stimulatory molecule, cGAMP promotes inflammatory signaling in a manner dependent on its downstream effector STING (14,15).”
Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L., Worthen, G. S., & Albelda, S. M. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,371 · cited 1×
“Collectively, these findings suggest that in addition to lymphocytes, granulocytic cells may also play a role in restricting metastatic colonization of Enpp1-KO cells, in line with previous reports showing an anti-tumor and pro-inflammatory effect of CD11b+Ly6G+ cells (28-30).”
ResultTumor mutational burden and response rate to PD-1 inhibition
Yarchoan, M., Hopkins, A., & Jaffee, E. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1713444 · Cited by 3,230 · cited 1×
“In line with its role modulating tumor immune responses, we found that ENPP1 expression within a given cancer type negatively correlates with its overall response rate to anti-PD1/PD-L1 therapy (35).”
BackgroundHoadley, K. A., Yau, C., Hinoue, T., Wolf, D. M., Lazar, A. J., Drill, E., Shen, R., Taylor, A. M., Cherniack, A. D., Thorsson, V., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.022 · Cited by 2,546 · cited 1×
“gov/about-data/publications/pancanatlas) (43).”
Self-citationThe causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
Self-citationcGAS surveillance of micronuclei links genome instability to innate immunity
Mackenzie, K. J., Carroll, P., Martin, C.-A., Murina, O., Fluteau, A., Simpson, D. J., Olova, N., Sutcliffe, H., Rainger, J. K., Leitch, A., et al. (2017) · Nature · doi:10.1038/nature23449 · Cited by 1,752 · cited 1×
“Micronuclear envelopes are highly rupture-prone, often exposing genomic double-stranded DNA (dsDNA) to the cytosol (1,9-12).”
BackgroundChromosomal instability drives metastasis through a cytosolic DNA response
Bakhoum, S. F., Ngo, B., Laughney, A. M., Cavallo, J.-A., Murphy, C. J., Ly, P., Shah, P., Sriram, R. K., Watkins, T. B. K., Taunk, N. K., et al. (2018) · Nature · doi:10.1038/nature25432 · Cited by 1,593 · cited 10×
“We had recently shown that tumor cell-intrinsic STING activation by intracellular cGAMP can also promote cellular migration and metastasis (1).”
BackgroundMethodInfluentialSelf-citationCorrales, L., Glickman, L. H., McWhirter, S. M., Kanne, D. B., Sivick, K. E., Katibah, G. E., Woo, S.-R., Lemmens, E., Banda, T., Leong, J. J., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.031 · Cited by 1,560 · cited 1×
“Therapies that activate STING (also known as STING agonists) have been the focus of intense investigation given their ability to elicit anti-tumor immunity through type I interferon signaling (42).”
BackgroundMitotic progression following DNA damage enables pattern recognition within micronuclei
Harding, S. M., Benci, J. L., Irianto, J., Discher, D. E., Minn, A. J., & Greenberg, R. A. (2017) · Nature · doi:10.1038/nature23470 · Cited by 1,508 · cited 1×
“Micronuclear envelopes are highly rupture-prone, often exposing genomic double-stranded DNA (dsDNA) to the cytosol (1,9-12).”
BackgroundCytoplasmic chromatin triggers inflammation in senescence and cancer
Dou, Z., Ghosh, K., Vizioli, M. G., Zhu, J., Sen, P., Wangensteen, K. J., Simithy, J., Lan, Y., Lin, Y., Zhou, Z., et al. (2017) · Nature · doi:10.1038/nature24050 · Cited by 1,335 · cited 1×
“cence-associated secretory phenotype, rather than interferon (IFN)-stimulated genes (16).”
BackgroundAllele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution
McGranahan, N., Rosenthal, R., Hiley, C. T., Rowan, A. J., Watkins, T. B. K., Wilson, G. A., Birkbak, N. J., Veeriah, S., Van Loo, P., Herrero, J., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.001 · Cited by 1,298
Self-citationDNA breaks and chromosome pulverization from errors in mitosis
Crasta, K., Ganem, N. J., Dagher, R., Lantermann, A. B., Ivanova, E. V., Pan, Y., Nezi, L., Protopopov, A., Chowdhury, D., & Pellman, D. (2012) · Nature · doi:10.1038/nature10802 · Cited by 1,227 · cited 1×
“Chromosome segregation errors lead to the formation of micronuclei (7,8).”
BackgroundcGAS is essential for cellular senescence
Yang, H., Wang, H., Ren, J., Chen, Q., & Chen, Z. J. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705499114 · Cited by 1,009 · cited 1×
“Micronuclear envelopes are highly rupture-prone, often exposing genomic double-stranded DNA (dsDNA) to the cytosol (1,9-12).”
BackgroundNeoantigen-directed immune escape in lung cancer evolution
The TRACERx consortium, Rosenthal, R., Cadieux, E. L., Salgado, R., Bakir, M. A., Moore, D. A., Hiley, C. T., Lund, T., Tanić, M., Reading, J. L., et al. (2019) · Nature · doi:10.1038/s41586-019-1032-7 · Cited by 946
Self-citationVoorwerk, L., Slagter, M., Horlings, H. M., Sikorska, K., van de Vijver, K. K., de Maaker, M., Nederlof, I., Kluin, R. J. C., Warren, S., Ong, S., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0432-4 · Cited by 905 · cited 1×
“We next analyzed the mRNA expression levels of CGAS and ENPP1 in 228 bladder cancers treated with anti-PD-L1 (aPD-L1) therapy and a smaller cohort of 52 TNBC tumors treated with aPD1 (36,37).”
MethodTargeting immunosuppressive adenosine in cancer
Vijayan, D., Young, A., Teng, M. W. L., & Smyth, M. J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.86 · Cited by 840 · cited 3×
“Extracellular cGAMP hydrolysis by ENPP1 generates adenosine We next explored the fate of tumor-derived extracellular cGAMP and asked whether the breakdown products of this metabolite might contribute to the production of extracellular adenosine, an immune-suppressive and tumor-promoting metabolite (25).”
BackgroundAbe, T., & Barber, G. N. (2014) · Journal of Virology · doi:10.1128/jvi.00037-14 · Cited by 767 · cited 1×
“A potent immune-stimulatory molecule, cGAMP promotes inflammatory signaling in a manner dependent on its downstream effector STING (14,15).”
BackgroundCatastrophic nuclear envelope collapse in cancer cell micronuclei
Hatch, E. M., Fischer, A. H., Deerinck, T. J., & Hetzer, M. W. (2013) · Cell · doi:10.1016/j.cell.2013.06.007 · Cited by 741 · cited 1×
“Micronuclear envelopes are highly rupture-prone, often exposing genomic double-stranded DNA (dsDNA) to the cytosol (1,9-12).”
BackgroundThe Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment
Bakhoum, S. F., & Cantley, L. C. (2018) · Cell · doi:10.1016/j.cell.2018.08.027 · Cited by 717 · cited 2×
“In addition to the generation of chromosome copy number heterogeneity, which serves as a substrate for natural selection, CIN also promotes tumor progression by inducing chronic inflammatory signaling leading to increased cancer cell migration and invasion (1,6).”
BackgroundSelf-citationKim, K., Skora, A. D., Li, Z., Liu, Q., Tam, A. J., Blosser, R. L., Diaz, L. A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410626111 · Cited by 676
D’Angelo, S. P., Larkin, J., Sosman, J. A., Lebbé, C., Brady, B., Neyns, B., Schmidt, H., Hassel, J. C., Hodi, F. S., Lorigan, P., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.9258 · Cited by 650 · cited 1×
“Unlike cutaneous melanoma, mucosal melanoma is characterized by elevated CIN, reduced tumor mutational burden, and increased resistance to immune checkpoint blockade (32,33).”
BackgroundSelf-citationMarcus, A., Mao, A. J., Lensink-Vasan, M., Wang, L., Vance, R. E., & Raulet, D. H. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.016 · Cited by 611 · cited 4×
“S1D), suggesting that cGAMP is readily exported from cancer cells, as previously proposed (17-19).”
BackgroundResultInfluentialAnti-CD73 antibody therapy inhibits breast tumor growth and metastasis
Stagg, J., Divisekera, U., McLaughlin, N., Sharkey, J., Pommey, S., Denoyer, D., Dwyer, K. M., & Smyth, M. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908801107 · Cited by 572 · cited 1×
“Through its ability to bind extracellular adenosine receptors in both tumor and immune cells, adenosine promotes cancer cell migration and imparts potent immune suppressive effects (25,27).”
BackgroundHydrolysis of 2′3′-cGAMP by ENPP1 and design of nonhydrolyzable analogs
Li, L., Yin, Q., Kuss, P., Maliga, Z., Millán, J. L., Wu, H., & Mitchison, T. J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1661 · Cited by 533 · cited 2×
“Among the large number of differentially-expressed genes, ENPP1, stood out because of its reported role as a negative regulator of cGAMP (21).”
BackgroundGenome stability is ensured by temporal control of kinetochore–microtubule dynamics
Bakhoum, S. F., Thompson, S. L., Manning, A. L., & Compton, D. A. (2009) · Nature Cell Biology · doi:10.1038/ncb1809 · Cited by 453 · cited 1×
“ENPP1 is upregulated in cells with CIN To investigate the status of cGAS-STING signaling in cancer cells with CIN, we used a human triple-negative breast cancer (TNBC) cell line, MDA-MB-231, that was engineered to exhibit different rates of CIN through overexpression of the kinesin13 proteins, Kif2b or MCAK, or the do…”
MethodSelf-citationPervasive chromosomal instability and karyotype order in tumour evolution
Watkins, T. B. K., Lim, E. L., Petkovic, M., Elizalde, S., Birkbak, N. J., Wilson, G. A., Moore, D. A., Grönroos, E., Rowan, A., Dewhurst, S. M., et al. (2020) · Nature · doi:10.1038/s41586-020-2698-6 · Cited by 370 · cited 1×
“Given the pervasive nature of CIN in human cancer (4), tumor cells must cope with the presence of persistent inflammatory signaling arising from cGAS-sensing of cytosolic dsDNA.”
BackgroundSelf-citationCarozza, J. A., Böhnert, V., Nguyen, K. C., Skariah, G., Shaw, K. E., Brown, J. A., Rafat, M., von Eyben, R., Graves, E. E., Glenn, J. S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0028-4 · Cited by 357 · cited 4×
“S1D), suggesting that cGAMP is readily exported from cancer cells, as previously proposed (17-19).”
BackgroundInfluentialCancer-Cell-Intrinsic cGAS Expression Mediates Tumor Immunogenicity
Schadt, L., Sparano, C., Schweiger, N. A., Silina, K., Cecconi, V., Lucchiari, G., Yagita, H., Guggisberg, E., Saba, S., Nascakova, Z., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.065 · Cited by 298 · cited 3×
“S1D), suggesting that cGAMP is readily exported from cancer cells, as previously proposed (17-19).”
BackgroundResultJohnstone, C. N., Smith, Y. E., Cao, Y., Burrows, A. D., Cross, R. S. N., Ling, X., Redvers, R. P., Doherty, J. P., Eckhardt, B. L., Natoli, A. L., et al. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.017830 · Cited by 207 · cited 1×
“LMB, a more metastatic E0771 derivative (22), had significantly increased levels of ENPP1 mRNA (Supplementary Fig.”
Self-citationStructural insights into cGAMP degradation by Ecto-nucleotide pyrophosphatase phosphodiesterase 1
Kato, K., Nishimasu, H., Oikawa, D., Hirano, S., Hirano, H., Kasuya, G., Ishitani, R., Tokunaga, F., & Nureki, O. (2018) · Nature Communications · doi:10.1038/s41467-018-06922-7 · Cited by 176
Chuang, C.-H., Greenside, P. G., Rogers, Z. N., Brady, J. J., Yang, D., Ma, R. K., Caswell, D. R., Chiou, S.-H., Winters, A. F., Grüner, B. M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4285 · Cited by 156 · cited 2×
“We next analyzed ENPP1 expression in the various stages of tumorigenesis in a genetically engineered mouse model of lung adenocarcinoma driven by oncogenic KRAS and loss of Trp53 (23).”
BackgroundSelf-citationAltered Bone Development and an Increase in FGF-23 Expression in Enpp1−/− Mice
Mackenzie, N. C. W., Zhu, D., Milne, E. M., van 't Hof, R., Martin, A., Quarles, D. L., Millán, J. L., Farquharson, C., & MacRae, V. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032177 · Cited by 143 · cited 1×
“One possible mechanism by which ENPP1 would facilitate tumor spread to the bone is through its contribution to pyrophosphate metabolism, promoting bone remodeling (39).”
BackgroundCarozza, J. A., Brown, J. A., Böhnert, V., Fernández, D., AlSaif, Y., Mardjuki, R. E., Smith, M. A., & Li, L. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.07.007 · Cited by 121
Chromosome Pulverization in Human Cells With Micronuclei 2
Hatao, K. A. T. O., & Sandberg, A. A. (1968) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/40.1.165 · Cited by 94 · cited 1×
“Chromosome segregation errors lead to the formation of micronuclei (7,8).”
BackgroundEnpp1: A Potential Facilitator of Breast Cancer Bone Metastasis
Lau, W. M., Doucet, M., Stadel, R. P., Huang, D. C. S., WEBER, K. L., & Kominsky, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066752 · Cited by 77 · cited 1×
“Previous work has linked ENPP1 to the ability of tumor cells to disseminate especially in the context of bone metastasis (38), yet the precise mechanisms underlying this relationship had remained poorly understood.”
BackgroundFischer, M. A., Davies, M. L., Reider, I. E., Heipertz, E. L., Epler, M., Sei, J. J., Ingersoll, M. A., van Rooijen, N., Randolph, G. J., & Norbury, C. C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002374 · Cited by 67 · cited 1×
“Collectively, these findings suggest that in addition to lymphocytes, granulocytic cells may also play a role in restricting metastatic colonization of Enpp1-KO cells, in line with previous reports showing an anti-tumor and pro-inflammatory effect of CD11b+Ly6G+ cells (28-30).”
ResultAccurate measurement of endogenous adenosine in human blood
Löfgren, L., Pehrsson, S., Hägglund, G., Tjellström, H., & Nylander, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205707 · Cited by 54
Liu, Y., O’Leary, C. E., Wang, L. S., Bhatti, T. R., Dai, N., Kapoor, V., Liu, P., Mei, J., Guo, L., Oliver, P. M., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1061175 · Cited by 43 · cited 1×
“Collectively, these findings suggest that in addition to lymphocytes, granulocytic cells may also play a role in restricting metastatic colonization of Enpp1-KO cells, in line with previous reports showing an anti-tumor and pro-inflammatory effect of CD11b+Ly6G+ cells (28-30).”
ResultDiagnostic Role of Chromosomal Instability in Melanoma
Dabas, N., Byrnes, D. M., Rosa, A. M., Eller, M. S., & Grichnik, J. M. (2012) · Journal of Skin Cancer · doi:10.1155/2012/914267 · Cited by 21 · cited 1×
“Unlike cutaneous melanoma, mucosal melanoma is characterized by elevated CIN, reduced tumor mutational burden, and increased resistance to immune checkpoint blockade (32,33).”
BackgroundRe-awakening Innate Immune Signaling in Cancer: The Development of Highly Potent ENPP1 Inhibitors
Cogan, D. A., & Bakhoum, S. F. W. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.11.001 · Cited by 15 · cited 1×
“Through extensive assessment of ENPP1 mRNA and protein expression levels across human tumors, our work positions ENPP1 into the broader clinical context and makes the case for the development of ENPP1 inhibitors for the treatment of advanced and chromosomally unstable cancers (19,40,41).”
BackgroundSelf-citation
Cited by
The cGAS–STING pathway and cancer
Samson, N., & Ablasser, A. (2022) · Nature Cancer · doi:10.1038/s43018-022-00468-w · Cited by 668
Roles of natural killer cells in immunity to cancer, and applications to immunotherapy
Wolf, N. K., Kissiov, D. U., & Raulet, D. H. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00732-1 · Cited by 577
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Garland, K. M., Sheehy, T. L., & Wilson, J. T. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00750 · Cited by 357
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Butterfield, L. H., & Najjar, Y. G. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00973-8 · Cited by 330
“Moreover, Enpp1 -knockout mice have been shown to be more sensitive to immune checkpoint blockade in models of colorectal and breast cancers 47 .”
Non-cell-autonomous cancer progression from chromosomal instability
Li, J., Hubisz, M. J., Earlie, E. M., Duran, M. A., Hong, C., Varela, A. A., Lettera, E., Deyell, M., Tavora, B., Havel, J. J., et al. (2023) · Nature · doi:10.1038/s41586-023-06464-z · Cited by 307
Self-citation
Metadata
- Authors
- Li, J., Duran, M. A., Dhanota, N., Chatila, W. K., Bettigole, S. E., Kwon, J., Sriram, R. K., Humphries, M. P., Salto-Tellez, M., James, J. A., Hanna, M. G., Melms, J. C., Vallabhaneni, S., Litchfield, K., Usaite, I., Biswas, D., Bareja, R., Li, H. W., Martin, M. L., Dorsaint, P., Cavallo, J.-A., Li, P., Pauli, C., Gottesdiener, L., DiPardo, B. J., Hollmann, T. J., Merghoub, T., Wen, H. Y., Reis-Filho, J. S., Riaz, N., Su, S.-S. M., Kalbasi, A., Vasan, N., Powell, S. N., Wolchok, J. D., Elemento, O., Swanton, C., Shoushtari, A. N., Parkes, E. E., Izar, B., & Bakhoum, S. F.
- Affiliations
- Memorial Sloan Kettering Cancer Center (US)
- 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
- 4Volastra Therapeutics Inc., New York, New York.
- Weill Cornell Medicine (US)
- Queen's University Belfast (GB)
- 6Precision Medicine Centre of Excellence, Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom.
- Columbia University Irving Medical Center (US)
- Harvard University (US)
- The Francis Crick Institute (GB)
- 9Columbia Center for Translational Immunology, New York, New York.
- 13Englander Institute for Precision Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, New York.
- 14Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York.
- University Hospital Zurich (CH)
- University of California, Los Angeles (US)
- University of Oxford (GB)
- Corresponding author
- Bakhoum, Samuel F.
- ORCID
- Li, Jun
- Chatila, Walid K.
- Kwon, John
- Humphries, Matthew P.
- James, Jacqueline A.
- Hanna, Matthew G.
- Melms, Johannes C.
- Litchfield, Kevin
- Usaite, Ieva
- Biswas, Dhruva
- Bareja, Rohan
- Li, Hao Wei
- Martin, Maria Laura
- Dorsaint, Princesca
- Pauli, Chantal
- Gottesdiener, Lee
- Hollmann, Travis J.
- Merghoub, Taha
- Wen, Hannah Y.
- Reis-Filho, Jorge S.
- Riaz, Nadeem
- Kalbasi, Anusha
- Vasan, Neil
- Powell, Simon N.
- Wolchok, Jedd D.
- Elemento, Olivier
- Swanton, Charles
- Shoushtari, Alexander N.
- Parkes, Eileen E.
- Izar, Benjamin
- Bakhoum, Samuel F.
- Venue
- Cancer Discovery
- Published
- 2020-12-28
- Volume
- 11
- Issue
- 5
- Pages
- 1212-1227
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC8102348
- OpenAlex
- W3115597636
- Cited by
- 312
- References
- 47
- Citations by year
- 2026: 53 · 2025: 58 · 2024: 71 · 2023: 61 · 2022: 47 · 2021: 22
- FWCI
- 20.42
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- NIH (DP5OD026395, K08CA222663, U54CA225088)
- NCI (P50CA247749)
- MSKCC (P30-CA008748)
- Burroughs Wellcome Fund Career Award for Medical Scientists Louis V. Gerstner Jr. Scholars Program Herbert Irving Comprehensive Cancer Center (P30CA013696)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Keywords
- ENPP1, metastasis, immune evasion, cGAS-STING pathway, extracellular adenosine, chromosomal instability, tumor inflammation, immune checkpoint inhibitor resistance, PD-1/PD-L1 blockade, tumor immune infiltration, ectonucleotidases, tumor microenvironment
- MeSH terms
- Animals, Humans, Hydrolysis, Immunotherapy, Mice, Inbred BALB C, Neoplasm Metastasis, Neoplasms, Nucleotides, Cyclic, Tumor Escape, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.